Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) SHH

51.97

-0.53(-1.01%)

Updated at June 02 03:00PM

Currency In CNY

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Address

Building 7

Beijing, 102200

China

Phone

86 10 6074 8199

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1556

First IPO Date

June 21, 2021

Key Executives

NameTitlePayYear Born
Dao Sheng XieCore Technical Staff01985
Ming Juan WangCore Technical Staff01976
Guangtao HaoDeputy GM & Core Technician01980
Huan LuoDeputy GM & Director01984
Yan ShaoDeputy General Manager01978
Li Ping WeiSecretary & Director01989
Yujing LiuGM & Director01982
Zhi Jiao ZhangAccounting Supervisor & Director01979
Yuanbo LiDeputy General Manager01979

Description

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.